# Trevi Therapeutics, Inc. (TRVI): MoatMap facts

As of 27 Oct 2026. Research data, not investment advice.

As of 27 Oct 2026, MoatMap's StockRank for Trevi Therapeutics, Inc. (TRVI) is 20/100, ranked against 24,000+ stocks in 35 markets (Quality 39, Value 24, Momentum 38, each scored against its sector).

- StockRank: 20/100, a percentile across 24,000+ stocks in 35 markets (100 is best).
- Quality 39, Value 24, Momentum 38: each a 0-100 percentile within Healthcare.
- Position: #21,286 overall, #1,920 in Healthcare.
- Listing: United States, NGM; Healthcare / Biotechnology.
- Last close: 12.51 USD on 26 Oct 2026.
- Insider filings, last 180 days: directors sold USD 594K.

Source: https://moatmap.ai/stock/TRVI
How the scores work: https://moatmap.ai/methodology
Does StockRank work? The public record: https://moatmap.ai/decile-tracker